Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$1.85 - $2.57 $67,617 - $93,933
-36,550 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$1.59 - $2.51 $58,114 - $91,740
36,550 New
36,550 $74,000
Q1 2020

May 15, 2020

SELL
$1.39 - $3.19 $15,328 - $35,179
-11,028 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$1.96 - $2.81 $21,614 - $30,988
11,028 New
11,028 $28,000

Others Institutions Holding SYBX

About SYNLOGIC, INC.


  • Ticker SYBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,229,600
  • Market Cap $103M
  • Description
  • Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...
More about SYBX
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.